Gnb2-flox Mouse
Common Name
Gnb2-flox
제품 ID
S-CKO-17477
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-14693-Gnb2-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Gnb2-flox Mouse (카탈로그 번호 S-CKO-17477)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Gnb2-flox
품종 계통계통 ID
CKOCMP-14693-Gnb2-B6J-VB
유전자명
제품 ID
S-CKO-17477
유전자 별칭
Gnb-2, Hg2c1
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 5
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000031726
NCBI 전사체 ID
NM_010312
타겟 영역
Exon 2~10
유효 영역 크기
~3.3 kb
유전자 연구 개요
Gnb2, or Guanine-nucleotide binding protein 2, encodes for the β2 subunit (Gβ2) of the G-protein complex. G-proteins mediate signalling pathways involved in diverse cellular functions [2,3,5,9]. The G-protein complex, consisting of Gα and Gβγ units, is integral in integrating signals between receptors and effector proteins [3,9].
Mutations in Gnb2 have been associated with several diseases. In Sturge-Weber syndrome (SWS), a rare neurovascular disorder, a somatic mutation in Gnb2 was found in one patient negative for the common GNAQ mutation. This mutation in Gnb2, like the GNAQ mutation, may lead to failure of G-protein complex reassembly, dysregulated MAPK signalling, and reduced synthesis of Yes-associated protein (YAP), suggesting a role of the Hippo signalling pathway in SWS vascular pathogenesis [1,8]. In addition, de novo missense variants in Gnb2 can cause syndromic intellectual disability with variable dysmorphism and extraneurologic features [3,5,9]. A heterozygous mutation in Gnb2 clinically leads to sinus bradycardia and sinus node dysfunction [6].
In cancer, Gnb2 is notably up-regulated in twenty-three cancer types relative to controls, and its elevated expression is associated with reduced overall survival in Liver Hepatocellular Carcinoma and Rectum Adenocarcinoma, suggesting it plays a role in the tumorigenesis of these cancers [2]. Also, in breast cancer, miR-142-3p can improve paclitaxel sensitivity by targeting Gnb2 and inhibiting autophagy through the GNB2-AKT-mTOR pathway [7]. In colorectal cancer, lncRNA CCAT2 promotes cancer cell proliferation and metastasis by regulating GNB2 expression and activating the ERK and Wnt signalling pathways [10]. Lidocaine-induced apoptosis in rat pheochromocytoma PC12 cells is mediated by Gnb2 [4].
In conclusion, Gnb2 is crucial for the normal function of G-protein-mediated signalling pathways. Its mutations and dysregulation are associated with various diseases including SWS, neurodevelopmental disorders, sinus node dysfunction, and multiple cancers. Understanding Gnb2's role through these disease associations helps in elucidating disease mechanisms and may potentially guide future therapeutic strategies.
References:
1. Yeom, SangEun, Comi, Anne M. 2022. Updates on Sturge-Weber Syndrome. In Stroke, 53, 3769-3779. doi:10.1161/STROKEAHA.122.038585. https://pubmed.ncbi.nlm.nih.gov/36263782/
2. Zhang, L, Sahar, A M, Li, C, Feng, W, Hameed, Y. 2022. A detailed multi-omics analysis of GNB2 gene in human cancers. In Brazilian journal of biology = Revista brasleira de biologia, 84, e260169. doi:10.1590/1519-6984.260169. https://pubmed.ncbi.nlm.nih.gov/35730811/
3. Tan, Natalie B, Pagnamenta, Alistair T, Ferla, Matteo P, Christodoulou, John, White, Susan M. 2021. Recurrent de novo missense variants in GNB2 can cause syndromic intellectual disability. In Journal of medical genetics, 59, 511-516. doi:10.1136/jmedgenet-2020-107462. https://pubmed.ncbi.nlm.nih.gov/34183358/
4. Tan, Yonghong, Wang, Qiong, Zhao, Baisong, She, Yingjun, Bi, Xiaobao. 2016. GNB2 is a mediator of lidocaine-induced apoptosis in rat pheochromocytoma PC12 cells. In Neurotoxicology, 54, 53-64. doi:10.1016/j.neuro.2016.03.015. https://pubmed.ncbi.nlm.nih.gov/27018092/
5. Lansdon, Lisa A, Fleming, Emily A, Viso, Florencia Del, Sullivan, Bonnie R, Saunders, Carol J. 2021. Second patient with GNB2-related neurodevelopmental disease: Further evidence for a gene-disease association. In European journal of medical genetics, 64, 104243. doi:10.1016/j.ejmg.2021.104243. https://pubmed.ncbi.nlm.nih.gov/33971351/
6. Kayser, Anne, Dittmann, Sven, Hamidi, Jassin, Hansen, Arne, Schulze-Bahr, Eric. 2024. Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A). In Stem cell research, 78, 103446. doi:10.1016/j.scr.2024.103446. https://pubmed.ncbi.nlm.nih.gov/38776645/
7. Shi, Yingxiang, Wang, Jing, Tao, Shuang, Shi, Yurong, Yang, Qingling. 2022. miR-142-3p improves paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR Pathway. In Cellular signalling, 103, 110566. doi:10.1016/j.cellsig.2022.110566. https://pubmed.ncbi.nlm.nih.gov/36539001/
8. Fjær, Roar, Marciniak, Katarzyna, Sundnes, Olav, Haraldsen, Guttorm, Selmer, Kaja Kristine. . A novel somatic mutation in GNB2 provides new insights to the pathogenesis of Sturge-Weber syndrome. In Human molecular genetics, 30, 1919-1931. doi:10.1093/hmg/ddab144. https://pubmed.ncbi.nlm.nih.gov/34124757/
9. Fukuda, Tokiko, Hiraide, Takuya, Yamoto, Kaori, Ogata, Tsutomu, Saitsu, Hirotomo. 2019. Exome reports A de novo GNB2 variant associated with global developmental delay, intellectual disability, and dysmorphic features. In European journal of medical genetics, 63, 103804. doi:10.1016/j.ejmg.2019.103804. https://pubmed.ncbi.nlm.nih.gov/31698099/
10. Tian, Jinhai, Cao, Xu, Jiang, Zongying, Zhao, Sien, Sun, Jianmin. . LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression. In Cancer medicine, 13, e70169. doi:10.1002/cam4.70169. https://pubmed.ncbi.nlm.nih.gov/39225546/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
